While further research is needed, our findings suggest that it may be beneficial to use erlotinib, a relatively non-toxic targeted agent, to initially treat patients with advanced lung cancer, rather than use conventional chemotherapy regimens.
While further research is needed, our findings suggest that it may be beneficial to use erlotinib, a relatively non-toxic targeted agent, to initially treat patients with advanced lung cancer, rather than use conventional chemotherapy regimens.
I don't spend most of my life in front of the media.




(12 votes, 3.08 )Acting is real important to me. I love it, and it's something I care about.




(16 votes, 3.25 )I've made up so many stories about my name, I can't remember.




(11 votes, 3.64 )Don’t aspire to make a living, aspire to make a difference.




(10 votes, 4.50 )Do what you have to do to do what you want to do.




(9 votes, 4.78 )I never really had the classic struggle. I had faith.




(5 votes, 4.40 )I'm not a film buff. I don't watch a lot of movies.




(8 votes, 3.50 )Do Not Sell My Personal Information
Exercise your consumer rights by contacting us below Privacy Policy
Personalized advertisements
Turning this off will opt you out of personalized advertisements delivered from Google on this website.
